Paclitaxel

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47933 publications

Endometrial Cancer: A Review.

Endometrial Cancer: A Review.

Journal: JAMA

Published: April 13, 2026

A systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome‒blood‒brain axis of female mice.

A systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome‒blood‒brain axis of female mice.

Journal: Gut microbes

Published: April 11, 2026

METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m 6 A-dependent translational upregulation of ABCB1.

METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m 6 A-dependent translational upregulation of ABCB1.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer.

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer.

Journal: JAMA network open

Published: April 10, 2026

Proteomics reveals extensive phosphoregulation of outer kinetochore protein KNL1.

Proteomics reveals extensive phosphoregulation of outer kinetochore protein KNL1.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

In brief: Optune Pax - a portable device for pancreatic cancer.

In brief: Optune Pax - a portable device for pancreatic cancer.

Journal: The Medical letter on drugs and therapeutics

Published: April 10, 2026

Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report.

Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report.

Journal: Cureus

Published: April 08, 2026

ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy.

ROS-responsive mPEG-PCL nanoparticles for co-delivery of paclitaxel prodrug and R848 in synergistic chemo-immunotherapy.

Journal: Biomaterials science

Published: April 07, 2026

FoTO1 orchestrates Taxol biosynthesis through catalytic and non-catalytic mechanisms.

FoTO1 orchestrates Taxol biosynthesis through catalytic and non-catalytic mechanisms.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio 33 (2025) 101993].

Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio 33 (2025) 101993].

Journal: Materials today. Bio

Published: April 02, 2026

An In-Field Recurrent Cervical Cancer Case After Chemoradiotherapy With a Marked Response to Pembrolizumab Combined With TC (Paclitaxel-Carboplatin) Therapy: A Case Report.

An In-Field Recurrent Cervical Cancer Case After Chemoradiotherapy With a Marked Response to Pembrolizumab Combined With TC (Paclitaxel-Carboplatin) Therapy: A Case Report.

Journal: Cureus

Published: April 01, 2026

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Showing 1-12 of 47,933

Last Updated: 04/28/2026